Basic Information
| RNALocate ID: | RLID:11002642 |
| RNA Symbol: | hsa-miR-324-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-324-5p |
| RNA ID: | miRBase:MIMAT0000761 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 20976003 |
| Tissue/Cell Line: | Breast cancer cell line (MCF-7) |
| Method: | Microarray |
| Description: | Because of the suggested roles of extracellular miRNAs in signaling and diagnosis, we investigated whether the intracellular and extracellular miRNA composition are the same. To answer this question, we performed microRNA microarray analyses of MCF7 cellular (c) and extracellular (x) RNAs (Figure 2A), and found that about 66% of the released miRNAs are at an abundance that closely reflects the cellular miRNA abundance (Figures 2B and 2C). This finding is in agreement with a model wherein most, but not all miRNAs are released passively by mass action. Data are collected from Figure 2. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002070 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01002071 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002072 | Mitochondrion | Myotube | 27396686 |
| RLID:01002073 | Mitochondrion | Skeletal muscle cells | 27563705 |
| RLID:01002074 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002075 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002076 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002077 | Nucleolus | Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11002641 | Exosome | Serum | 18589210 |
| RLID:11002643 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002644 | Exosome | Renal cancer cells | 21670082 |
| RLID:11002645 | Exosome | Brain tissue | 23382797 |
| RLID:11002646 | Exosome | Plasma | 23663360 |
| RLID:11002647 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11002648 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000438 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine | |
| RLID-D:11001214 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-324-5p | Splenic marginal zone lymphoma | MNDR-E-MI-39935 |
| MNDR | hsa-miR-324-5p | Oral squamous cell carcinoma | MNDR-E-MI-39936 |
| MNDR | hsa-miR-324-5p | Large cell neuroendocrine cancer | MNDR-E-MI-39937 |
| MNDR | hsa-miR-324-5p | Medulloblastoma | MNDR-E-MI-39938 |
| MNDR | hsa-miR-324-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-39939 |
| MNDR | hsa-miR-324-5p | Lymphoma | MNDR-E-MI-39940 |
| MNDR | hsa-miR-324-5p | Lymphoma non-hodgkin | MNDR-E-MI-39941 |
| MNDR | hsa-miR-324-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-39942 |
| MNDR | hsa-miR-324-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-39943 |
| MNDR | hsa-miR-324-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-39944 |
| MNDR | hsa-miR-324-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-39945 |
| MNDR | hsa-miR-324-5p | Her2-receptor positive breast cancer | MNDR-E-MI-39946 |
| MNDR | hsa-miR-324-5p | Breast cancer luminal | MNDR-E-MI-39947 |
| MNDR | hsa-miR-324-5p | Lupus nephritis | MNDR-E-MI-39948 |
| MNDR | hsa-miR-324-5p | Prostate cancer | MNDR-E-MI-39949 |
| MNDR | hsa-miR-324-5p | Gastric cancer | MNDR-E-MI-39950 |
| MNDR | hsa-miR-324-5p | Alzheimer disease | MNDR-E-MI-39951 |
| MNDR | hsa-miR-324-5p | Esophageal carcinoma | MNDR-E-MI-39952 |
| MNDR | hsa-miR-324-5p | Dysautonomia familial | MNDR-E-MI-39953 |
| MNDR | hsa-miR-324-5p | Cardiovascular disease | MNDR-E-MI-39954 |
| MNDR | hsa-miR-324-5p | Lung cancer | MNDR-E-MI-39955 |
| MNDR | hsa-miR-324-5p | Down syndrome | MNDR-E-MI-39956 |
| MNDR | hsa-miR-324-5p | Parkinson disease | MNDR-E-MI-39957 |
| MNDR | hsa-miR-324-5p | Basal-like breast cancer | MNDR-E-MI-39958 |
| MNDR | hsa-miR-324-5p | Thyroid cancer | MNDR-E-MI-39959 |
| MNDR | hsa-miR-324-5p | Pancreatic cancer | MNDR-E-MI-39960 |
| MNDR | hsa-miR-324-5p | Melanoma | MNDR-E-MI-39961 |
| MNDR | hsa-miR-324-5p | Rectum adenocarcinoma | MNDR-E-MI-39962 |
| MNDR | hsa-miR-324-5p | Nephroblastoma | MNDR-E-MI-39963 |
| MNDR | hsa-miR-324-5p | Colon cancer | MNDR-E-MI-39964 |
| MNDR | hsa-miR-324-5p | Colon adenocarcinoma | MNDR-E-MI-39965 |
| MNDR | hsa-miR-324-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-39966 |
| MNDR | hsa-miR-324-5p | Ovarian cancer | MNDR-E-MI-39967 |
| MNDR | hsa-miR-324-5p | Prostate adenocarcinoma | MNDR-E-MI-39968 |
| MNDR | hsa-miR-324-5p | Carcinoma ductal breast | MNDR-E-MI-39969 |
| MNDR | hsa-miR-324-5p | Glioblastoma | MNDR-E-MI-39970 |
| MNDR | hsa-miR-324-5p | Astrocytoma | MNDR-E-MI-39971 |
| MNDR | hsa-miR-324-5p | Malignant glioma | MNDR-E-MI-39972 |
| MNDR | hsa-miR-324-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-39973 |
| MNDR | hsa-miR-324-5p | Temporal lobe epilepsy | MNDR-E-MI-39974 |
| MNDR | hsa-miR-324-5p | Osteosarcoma | MNDR-E-MI-39975 |
| MNDR | hsa-miR-324-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-39976 |
| MNDR | hsa-miR-324-5p | Uterine cancer | MNDR-E-MI-39977 |
| MNDR | hsa-miR-324-5p | Lung squamous cell carcinoma | MNDR-E-MI-39978 |
| MNDR | hsa-miR-324-5p | Lung adenocarcinoma | MNDR-E-MI-39979 |
| MNDR | hsa-miR-324-5p | Thyroid carcinoma | MNDR-E-MI-39980 |
| MNDR | hsa-miR-324-5p | Bladder urothelial carcinoma | MNDR-E-MI-39981 |
| MNDR | hsa-miR-324-5p | Pancreatic adenocarcinoma | MNDR-E-MI-39982 |
| MNDR | hsa-miR-324-5p | Carcinoma renal cell | MNDR-E-MI-39983 |
| MNDR | hsa-miR-324-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-39984 |
| MNDR | hsa-miR-324-5p | Clear cell renal cell carcinoma | MNDR-E-MI-39985 |
| MNDR | hsa-miR-324-5p | Cholangiocarcinoma | MNDR-E-MI-39986 |
| MNDR | hsa-miR-324-5p | Esophageal cancer | MNDR-E-MI-39987 |
| MNDR | hsa-miR-324-5p | Lung small cell carcinoma | MNDR-E-MI-39988 |
| MNDR | hsa-miR-324-5p | Synovial sarcoma | MNDR-E-MI-39989 |
| MNDR | hsa-miR-324-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-39990 |
| MNDR | hsa-miR-324-5p | Encephalomyelitis | MNDR-E-MI-39991 |
| MNDR | hsa-miR-324-5p | Breast invasive carcinoma | MNDR-E-MI-39992 |
| MNDR | hsa-miR-324-5p | Hepatocellular carcinoma | MNDR-E-MI-39993 |
| MNDR | hsa-miR-324-5p | Neuroblastoma | MNDR-E-MI-39994 |
| MNDR | hsa-miR-324-5p | Barrett's adenocarcinoma | MNDR-E-MI-39995 |
| MNDR | hsa-miR-324-5p | Hodgkin lymphoma | MNDR-E-MI-39996 |
| MNDR | hsa-miR-324-5p | Burkitt lymphoma | MNDR-E-MI-39997 |
| MNDR | hsa-miR-324-5p | Neuromyelitis optica | MNDR-E-MI-39998 |
| MNDR | hsa-miR-324-5p | Acute myelogenous leukemia | MNDR-E-MI-39999 |
| MNDR | hsa-miR-324-5p | Colorectal cancer | MNDR-E-MI-40000 |
| MNDR | hsa-miR-324-5p | Nasopharynx carcinoma | MNDR-E-MI-40001 |
| MNDR | hsa-miR-324-5p | Ependymoma | MNDR-E-MI-40002 |
| MNDR | hsa-miR-324-5p | Lupus vulgaris | MNDR-E-MI-40003 |
| MNDR | hsa-miR-324-5p | Nasopharyngeal cancer | MNDR-E-MI-40004 |
| MNDR | hsa-miR-324-5p | Prostatic neoplasms | MNDR-E-MI-40005 |
| MNDR | hsa-miR-324-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-40006 |
| MNDR | hsa-miR-324-5p | Lung injury | MNDR-E-MI-40007 |
| MNDR | hsa-miR-324-5p | Stroke lacunar | MNDR-E-MI-40008 |
| MNDR | hsa-miR-324-5p | Barrett's carcinogenesis | MNDR-E-MI-40009 |
| MNDR | hsa-miR-324-5p | Breast cancer her3+ negative | MNDR-E-MI-40010 |
| MNDR | hsa-miR-324-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-40011 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR1 | Homo sapiens | RR00038837 |
TOP